Xilio Therapeutics (XLO) Enterprise Value Growth (1y) (2021 - 2026)
Xilio Therapeutics (XLO) Enterprise Value Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 472.27 Bn | 467.47 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.18 Bn | 114.93 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.08 Bn | 61.32 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.86 Bn | 50.68 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn |
| 10 | Xilio Therapeutics | 147.13 Mn | -3.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -68.74% |
| Dec 31, 2025 | -148.74% |
| Sep 30, 2025 | -69.39% |
| Jun 30, 2025 | -62.18% |
| Mar 31, 2025 | -162.13% |
| Dec 31, 2024 | -23.68% |
| Sep 30, 2024 | -2.49% |
| Jun 30, 2024 | 0.58% |
| Mar 31, 2024 | 63.57% |
| Dec 31, 2023 | 62.87% |
| Sep 30, 2023 | 57.04% |
| Jun 30, 2023 | 52.71% |
| Mar 31, 2023 | 47.29% |
| Dec 31, 2022 | 39.22% |
| Sep 30, 2022 | -39.47% |
| Jun 30, 2022 | -32.51% |
| Mar 31, 2022 | -25.31% |
| Dec 31, 2021 | -929.49% |